[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Marine Biotechnology-EMEA Market Status and Trend Report 2013-2023

May 2018 | 150 pages | ID: M0042E2A9C9MEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Marine Biotechnology-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Marine Biotechnology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Marine Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Marine Biotechnology in EMEA, with company and product introduction, position in the Marine Biotechnology market
Market status and development trend of Marine Biotechnology by types and applications
Cost and profit status of Marine Biotechnology, and marketing status
Market growth drivers and challenges

The report segments the EMEA Marine Biotechnology market as:

EMEA Marine Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Europe
Middle East
Africa

EMEA Marine Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Marine Animal Technology
Marine Plant Technology

EMEA Marine Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Cosmetics
Pharmaceuticals
Fine Chemical
Nutritional Supplements

EMEA Marine Biotechnology Market: Players Segment Analysis (Company and Product introduction, Marine Biotechnology Sales Volume, Revenue, Price and Gross Margin):

Marinova
NEB
BiotechMarine
GlycoMar
Marine Biotech
Nofima
Sams
Aquapharm

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MARINE BIOTECHNOLOGY

1.1 Definition of Marine Biotechnology in This Report
1.2 Commercial Types of Marine Biotechnology
  1.2.1 Marine Animal Technology
  1.2.2 Marine Plant Technology
1.3 Downstream Application of Marine Biotechnology
  1.3.1 Cosmetics
  1.3.2 Pharmaceuticals
  1.3.3 Fine Chemical
  1.3.4 Nutritional Supplements
1.4 Development History of Marine Biotechnology
1.5 Market Status and Trend of Marine Biotechnology 2013-2023
  1.5.1 EMEA Marine Biotechnology Market Status and Trend 2013-2023
  1.5.2 Regional Marine Biotechnology Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Marine Biotechnology in EMEA 2013-2017
2.2 Consumption Market of Marine Biotechnology in EMEA by Regions
  2.2.1 Consumption Volume of Marine Biotechnology in EMEA by Regions
  2.2.2 Revenue of Marine Biotechnology in EMEA by Regions
2.3 Market Analysis of Marine Biotechnology in EMEA by Regions
  2.3.1 Market Analysis of Marine Biotechnology in Europe 2013-2017
  2.3.2 Market Analysis of Marine Biotechnology in Middle East 2013-2017
  2.3.3 Market Analysis of Marine Biotechnology in Africa 2013-2017
2.4 Market Development Forecast of Marine Biotechnology in EMEA 2018-2023
  2.4.1 Market Development Forecast of Marine Biotechnology in EMEA 2018-2023
  2.4.2 Market Development Forecast of Marine Biotechnology by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of Marine Biotechnology in EMEA by Types
  3.1.2 Revenue of Marine Biotechnology in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Marine Biotechnology in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Marine Biotechnology in EMEA by Downstream Industry
4.2 Demand Volume of Marine Biotechnology by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Marine Biotechnology by Downstream Industry in Europe
  4.2.2 Demand Volume of Marine Biotechnology by Downstream Industry in Middle East
  4.2.3 Demand Volume of Marine Biotechnology by Downstream Industry in Africa
4.3 Market Forecast of Marine Biotechnology in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MARINE BIOTECHNOLOGY

5.1 EMEA Economy Situation and Trend Overview
5.2 Marine Biotechnology Downstream Industry Situation and Trend Overview

CHAPTER 6 MARINE BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of Marine Biotechnology in EMEA by Major Players
6.2 Revenue of Marine Biotechnology in EMEA by Major Players
6.3 Basic Information of Marine Biotechnology by Major Players
  6.3.1 Headquarters Location and Established Time of Marine Biotechnology Major Players
  6.3.2 Employees and Revenue Level of Marine Biotechnology Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 MARINE BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Marinova
  7.1.1 Company profile
  7.1.2 Representative Marine Biotechnology Product
  7.1.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of Marinova
7.2 NEB
  7.2.1 Company profile
  7.2.2 Representative Marine Biotechnology Product
  7.2.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of NEB
7.3 BiotechMarine
  7.3.1 Company profile
  7.3.2 Representative Marine Biotechnology Product
  7.3.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of BiotechMarine
7.4 GlycoMar
  7.4.1 Company profile
  7.4.2 Representative Marine Biotechnology Product
  7.4.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of GlycoMar
7.5 Marine Biotech
  7.5.1 Company profile
  7.5.2 Representative Marine Biotechnology Product
  7.5.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of Marine Biotech
7.6 Nofima
  7.6.1 Company profile
  7.6.2 Representative Marine Biotechnology Product
  7.6.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of Nofima
7.7 Sams
  7.7.1 Company profile
  7.7.2 Representative Marine Biotechnology Product
  7.7.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of Sams
7.8 Aquapharm
  7.8.1 Company profile
  7.8.2 Representative Marine Biotechnology Product
  7.8.3 Marine Biotechnology Sales, Revenue, Price and Gross Margin of Aquapharm

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MARINE BIOTECHNOLOGY

8.1 Industry Chain of Marine Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MARINE BIOTECHNOLOGY

9.1 Cost Structure Analysis of Marine Biotechnology
9.2 Raw Materials Cost Analysis of Marine Biotechnology
9.3 Labor Cost Analysis of Marine Biotechnology
9.4 Manufacturing Expenses Analysis of Marine Biotechnology

CHAPTER 10 MARKETING STATUS ANALYSIS OF MARINE BIOTECHNOLOGY

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications